Microbix Biosystems Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 2/6

Microbix Biosystems yıllık ortalama 48.5% oranında kazançlarını artırırken, Biotechs sektöründe kazançlar growing at 19.3% annual. Gelirler growing yılda ortalama 13% oranında artmaktadır. Microbix Biosystems'in özkaynak karlılığı 18.1% ve net marjı 21.7%'dir.

Anahtar bilgiler

48.5%

Kazanç büyüme oranı

49.6%

EPS büyüme oranı

Biotechs Sektör Büyümesi51.1%
Gelir büyüme oranı13.0%
Özkaynak getirisi18.1%
Net Marj21.7%
Son Kazanç Güncellemesi30 Jun 2024

Yakın geçmiş performans güncellemeleri

Microbix Biosystems' (TSE:MBX) Shareholders Should Assess Earnings With Caution

Aug 22
Microbix Biosystems' (TSE:MBX) Shareholders Should Assess Earnings With Caution

Why Microbix Biosystems' (TSE:MBX) Earnings Are Weaker Than They Seem

Feb 21
Why Microbix Biosystems' (TSE:MBX) Earnings Are Weaker Than They Seem

Recent updates

Microbix Biosystems' (TSE:MBX) Shareholders Should Assess Earnings With Caution

Aug 22
Microbix Biosystems' (TSE:MBX) Shareholders Should Assess Earnings With Caution

Why Microbix Biosystems' (TSE:MBX) Earnings Are Weaker Than They Seem

Feb 21
Why Microbix Biosystems' (TSE:MBX) Earnings Are Weaker Than They Seem

Microbix Biosystems Inc. (TSE:MBX) Just Reported Earnings, And Analysts Cut Their Target Price

Feb 17
Microbix Biosystems Inc. (TSE:MBX) Just Reported Earnings, And Analysts Cut Their Target Price

Microbix Biosystems Inc.'s (TSE:MBX) Shares Climb 29% But Its Business Is Yet to Catch Up

Dec 23
Microbix Biosystems Inc.'s (TSE:MBX) Shares Climb 29% But Its Business Is Yet to Catch Up

Is Microbix Biosystems (TSE:MBX) Using Debt Sensibly?

Nov 03
Is Microbix Biosystems (TSE:MBX) Using Debt Sensibly?

Is Microbix Biosystems (TSE:MBX) Using Debt In A Risky Way?

Jul 22
Is Microbix Biosystems (TSE:MBX) Using Debt In A Risky Way?

Some Shareholders Feeling Restless Over Microbix Biosystems Inc.'s (TSE:MBX) P/S Ratio

May 17
Some Shareholders Feeling Restless Over Microbix Biosystems Inc.'s (TSE:MBX) P/S Ratio

Time To Worry? Analysts Are Downgrading Their Microbix Biosystems Inc. (TSE:MBX) Outlook

Dec 27
Time To Worry? Analysts Are Downgrading Their Microbix Biosystems Inc. (TSE:MBX) Outlook

Microbix Biosystems (TSE:MBX) Has A Pretty Healthy Balance Sheet

Aug 08
Microbix Biosystems (TSE:MBX) Has A Pretty Healthy Balance Sheet

Microbix Biosystems' (TSE:MBX) Solid Profits Have Weak Fundamentals

May 20
Microbix Biosystems' (TSE:MBX) Solid Profits Have Weak Fundamentals

Microbix Biosystems (TSE:MBX) Seems To Use Debt Quite Sensibly

Feb 06
Microbix Biosystems (TSE:MBX) Seems To Use Debt Quite Sensibly

One Microbix Biosystems Inc. (TSE:MBX) Analyst Just Made A Major Cut To Next Year's Estimates

Dec 28
One Microbix Biosystems Inc. (TSE:MBX) Analyst Just Made A Major Cut To Next Year's Estimates

Is Microbix Biosystems (TSE:MBX) A Risky Investment?

Oct 14
Is Microbix Biosystems (TSE:MBX) A Risky Investment?

Microbix Biosystems Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Aug 15
Microbix Biosystems Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

A Look At The Fair Value Of Microbix Biosystems Inc. (TSE:MBX)

May 17
A Look At The Fair Value Of Microbix Biosystems Inc. (TSE:MBX)

Most Shareholders Will Probably Find That The CEO Compensation For Microbix Biosystems Inc. (TSE:MBX) Is Reasonable

Mar 24
Most Shareholders Will Probably Find That The CEO Compensation For Microbix Biosystems Inc. (TSE:MBX) Is Reasonable

We Think Microbix Biosystems (TSE:MBX) Has A Fair Chunk Of Debt

Jan 29
We Think Microbix Biosystems (TSE:MBX) Has A Fair Chunk Of Debt

Gelir ve Gider Dağılımı

Microbix Biosystems nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.


Kazanç ve Gelir Geçmişi

TSX:MBX Gelir, gider ve kazançlar (CAD Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Jun 2423592
31 Mar 24244102
31 Dec 2322492
30 Sep 2317082
30 Jun 2317-382
31 Mar 2316-172
31 Dec 2217072
30 Sep 2219272
30 Jun 2220362
31 Mar 2221462
31 Dec 2120461
30 Sep 2119351
30 Jun 2116-351
31 Mar 2113-451
31 Dec 2012-641
30 Sep 2011-641
30 Jun 2011-141
31 Mar 2012-141
31 Dec 1913051
30 Sep 1913041
30 Jun 1913-841
31 Mar 1913-841
31 Dec 1812-941
30 Sep 1813-941
30 Jun 1812-141
31 Mar 1811-151
31 Dec 1711-141
30 Sep 1710-441
30 Jun 1711-241
31 Mar 1710-241
31 Dec 1610-241
30 Sep 1610140
30 Jun 168031
31 Mar 168031
31 Dec 158031
30 Sep 159131
30 Jun 159041
31 Mar 159031
31 Dec 148031
30 Sep 148031
30 Jun 149120
31 Mar 148130
31 Dec 139130

Kaliteli Kazançlar: MBX yüksek düzeyde nakit dışı kazança sahiptir.

Büyüyen Kar Marjı: MBX geçmişte karlı hale geldi.


Serbest Nakit Akışı ve Kazanç Analizi


Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: MBX son 5 yılda karlı hale geldi ve kazançlarını yıllık 48.5% oranında artırdı.

Büyüme Hızlandırma: MBX son bir yılda karlı hale geldi, bu da kazanç büyüme oranının 5 yıllık ortalamayla karşılaştırılmasını zorlaştırıyor.

Kazançlar vs. Sektör: MBX son bir yılda karlı hale geldi ve bu durum, geçmiş yıl kazanç büyümesinin Biotechs sektörüyle ( 16.6% ) karşılaştırılmasını zorlaştırıyor.


Özkaynak Getirisi

Yüksek ROE: MBX 'nin Özsermaye Getirisi ( 18.1% ) düşük olarak değerlendiriliyor.


Varlık Getirisi


Kullanılan Sermaye Getirisi


Geçmişte güçlü performans gösteren şirketleri keşfedin